Clinical trial · Observational
Aberrant Gene Expression Prostate Carcinoma
Identification of Aberant Gene Expression in Human Prostatic Carcinoma
NCT00868803CI-TRIAL-00117773active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The goal of the study is to gain a better understanding of the molecular changes responsible for causing prostate cancer and that examination of tissue and blood samples will help in the development of improved screening and therapeutic approaches.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Prostate Cancer | Malignant Prostate Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Eligibility
Eligibility (as posted)
- Sex
- Male
Show eligibility criteria text
Inclusion Criteria: * Diagnosed prostate cancer undergoing prostatectomy * Suspicion of prostate cancer undergoing biopsy - negative biopsy * Health volunteer (control group) - blood sample for PSA Exclusion Criteria: * Patients not fitting the inclusion criteria
References
Publications (0)
Data not yet available
No reference posted for this study.